Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OSI-7904L in Advanced Gastric or GEJ Adenocarcinoma
NCT00073502Phase 2Completed
- Sponsor
- OSI Pharmaceuticals
- Start
- Oct 2003
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of OSI-7904L in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, sponsored by OSI Pharmaceuticals. Started Oct 2003; status: completed.
02
Drugs
OSI-7904L
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT00073502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00073502.